4-(4-hydroxyphenyl)-3-methylbutan-2-one | 66422-88-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(4-hydroxyphenyl)-3-methylbutan-2-one
• CAS: 66422-88-6
• 化学式: C₁₁H₁₄O₂
• 分子量: 178.231
• InChiKey: RKONDNYXZKXHAL-UHFFFAOYSA-N

物化性质

• 沸点：
  118-119 °C(Press: 0.005 Torr)
• 密度：
  1.073 g/cm3(Temp: 19.5 °C)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  4-(4-hydroxyphenyl)-3-methyl-3-buten-2-one 在 nickel boride 、 氢气 作用下， 以 甲醇 为溶剂， 反应 3.0h， 以91%的产率得到4-(4-hydroxyphenyl)-3-methylbutan-2-one
  参考文献：
  名称：

  Selective hydrogenation of conjugated unsaturated ketones containing a hydroxyaryl substituent in the β-position

  摘要：

  A high selectivity was achieved in the Ni2B-catalyzed hydrogenation of alpha,beta-unsaturated ketones containing a hydroxyaryl (phenolic) substituent in the beta-position. The developed hydrogenation procedure was used to synthesize natural compounds of the phenylpropane series and their structural analogs.

  DOI：

  10.1134/s1070428017010055

文献信息

• Decarboxylative C_sp3–C_sp3 coupling for benzylation of unstable ketone enolates: synthesis of p-(acylethyl)phenols
  作者：Sasa Wang、Xinzheng Chen、Qiaoqiao Ao、Huifei Wang、Hongbin Zhai

  DOI：10.1039/c6cc03835b

  日期：——

  A new decarboxylative Csp3-Csp3 coupling approach for the benzylation of ketone enolates has been developed. A variety of raspberry ketone derivatives were conveniently synthesized in good to excellent yields under...

  已经开发出一种新的用于羧甲基化烯醇烯酸酯的脱羧Csp3-Csp3偶联方法。在高温条件下，可以方便地合成多种树莓酮衍生物，并具有良好的产率。
• METHODS OF MYOCARDIAL IMAGING
  申请人：Caravan D. Peter

  公开号：US20080058636A1

  公开（公告）日：2008-03-06

  Diagnostic compositions and methods for imaging collagen and/or assessing myocardial perfusion are described. The diagnostic compositions can include collagen binding peptides.

  本文描述了用于成像胶原蛋白和/或评估心肌灌注的诊断组合物和方法。诊断组合物可以包括胶原蛋白结合肽。
• Resolution of P-Hydroxyphenyl-2-Alkoxypropionic Acids
  申请人：Most Dieter

  公开号：US20080064897A1

  公开（公告）日：2008-03-13

  The present invention is aimed at a process for the preparation of enantiomerically enriched compounds of general formula (I). These are obtained by classical resolution of the corresponding acid using a chiral amino base in organic solvents.

  本发明旨在提供一种制备手性富集化合物（通式（I））的方法。该方法通过在有机溶剂中使用手性氨基碱对相应酸进行经典分离得到。
• Modulators of peroxisome proliferator activated receptors
  申请人：Brooks Alisa Dawn

  公开号：US20070276138A1

  公开（公告）日：2007-11-29

  Disclosed is a compound represented by Structural Formula (I): Ar is a substituted or unsubstituted aromatic group. Q is a covalent bond, —CH 2 — or —CH 2 CH 2 —; W is a substituted or unsubstituted alkylene or a substituted or unsubstituted heteroalkylene linking group from two to ten atoms in length, preferably from two to seven atoms in length. Phenyl Ring A is optionally substituted with up to four substituents in addition to R 1 and W. R 1 is —(CH 2 ) n —CH(OR 2 )—(CH 2 ) m E, —(CH)═C(OR 2 )—(CH 2 ) m E, —(CH 2 ) n —CH(Y)—(CH 2 ) m E or —(CH)═C(Y)—(CH 2 ) m E; wherein E is COOR 3 , C 1 -C 3 -alkylnitrile, carboxamide, sulfonamide, acylsulfonamide or tetrazole and wherein sulfonamide, acylsulfonamide and tetrazole are optionally substituted with one or more substituents independently selected from: C 1 -C 6 alkyl, haloalkyl and aryl-C 0-4 -alkyl; R 2 is —H, an aliphatic group, a substituted aliphatic group, haloalkyl, an aromatic group, a substituted aromatic group, —COR 4 , —COOR 4 , —CONR 5 R 6 , —C(S)R 4 , —C(S)OR 4 or —C(S)NR 5 R 6 . R 3 is —H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. Y is —O—, —CH 2 —, —CH 2 CH 2 — or —CH═CH— and is bonded to a carbon atom in Phenyl Ring A that is ortho to R 1 . R 4 -R 6 are independently —H, an aliphatic group, a substituted aliphatic group, an aromatic group or a substituted aromatic group. n and m are independently 0, 1 or 2.

  公开了一种化合物，其结构式表示为（I）：其中Ar是取代或未取代的芳香族基团。Q是共价键，-CH2-或- -；W是取代或未取代的烷基或取代或未取代的异烷基连接基团，长度为两到十个原子，优选长度为两到七个原子。苯环A可以选择性地用最多四个取代基取代R1和W。R1是-( )n-CH(OR2)-( )mE，-(CH)=C(OR2)-( )mE，-( )n-CH(Y)-( )mE或-(CH)=C(Y)-( )mE；其中E是COOR3，C1-C3-烷基腈，羧酰胺，磺酰胺，酰基磺酰胺或四唑，其中磺酰胺，酰基磺酰胺和四唑可以选择性地用一个或多个取代基取代，独立地选自C1-C6烷基，卤代烷基和芳基-C0-4-烷基；R2是-H，一种脂肪基，一种取代的脂肪基，卤代烷基，一种芳香基，一种取代的芳香基，-COR4，-COOR4，-CONR5R6，-C（S）R4，-C（S）OR4或-C（S）NR5R6；R3是-H，一种脂肪基，一种取代的脂肪基，一种芳香基或一种取代的芳香基；Y是-O-，- -，- -或-CH═CH-，并与苯环A中与R1正交的碳原子键合；R4-R6独立地是-H，一种脂肪基，一种取代的脂肪基，一种芳香基或一种取代的芳香基；n和m独立地为0、1或2。
• Renin Inhibitors
  申请人：Bayly Christopher I.

  公开号：US20090281103A1

  公开（公告）日：2009-11-12

  The present invention relates to novel renin inhibitors of the general Formula (I), and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds. These novel renin inhibitors are used in treating cardiovascular events and renal insufficiency.

  本发明涉及一种新型肾素抑制剂，其通式为（I），并且它们作为制备制药组合物的活性成分使用。该发明还涉及相关方面，包括化合物的制备过程。这些新型肾素抑制剂用于治疗心血管事件和肾功能不全。